SMTL ID : 4wa9.2 (1 other biounit)

The crystal structure of human abl1 wild type kinase domain in complex with axitinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x AXI: AXITINIB(Non-covalent)

AXI.1: 16 residues within 4Å: Chain A: L.22, G.23, Y.27, A.43, K.45, T.89, E.90, F.91, M.92, T.93, Y.94, G.95, N.142, L.144, A.154, F.156 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.22, A:L.22, A:Y.27, A:Y.27, A:F.91, A:A.154, A:F.156 Hydrogen bonds: A:T.89, A:M.92, A:M.92 Water bridges: A:F.156 pi-Stacking: A:Y.27

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pemovska, T. et al., Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation. Nature (2015)

Release Date

2015-02-11

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence